REGULATORY
PAFSC’s 2nd Committee Receives Report on Add’l Indication for Xeloda, Elplat
The Second Committee on Drugs of the Pharmaceutical Affairs and Food Sanitation Council (PAFSC) received on October 29 reports on additional indications for drugs including Chugai Pharmaceutical’s Xeloda (capecitabine) and Yakult Honsha’s Elplat IV Infusion Solution 50 mg/100 mg/200 mg…
To read the full story
Related Article
- Takeda’s Hib Vaccine to Be Reported to PAC in December
November 2, 2015
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- New Digital Minister Furukawa Pledges Push for Healthy Longevity
September 24, 2026
- MHLW Eyes Higher Long-Term Care Premiums for Wealthier Seniors
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





